Statin Therapy to Reduce Disease Progression From Liver Cirrhosis to Cancer

Trial Profile

Statin Therapy to Reduce Disease Progression From Liver Cirrhosis to Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Sep 2017

At a glance

  • Drugs Simvastatin (Primary)
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2017 Status changed from not yet recruiting to recruiting.
    • 16 Jun 2017 Planned initiation date changed from 1 Jun 2017 to 11 Sep 2017.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top